Numerous studies have demonstrated that CD133 expression increases as an outcome of the cell communication between tumoral cells and its niche in several cancers through cytokines secretion such as interleukins, TNFα/β, HGF, adipokines, and TGFβ (Table 1). This evidence concerns the gene TGFB1 and cancer.